カテゴリ： GlobalData, アメリカ, 企業調査

MiMedx Group Inc – Product Pipeline Analysis, 2018 Uate

◆英語タイトル：MiMedx Group Inc - Product Pipeline Analysis, 2018 Uate
◆商品コード：DATA904C12535
◆発行会社（調査会社）：GlobalData
◆発行日：2018年12月
◆ページ数：46
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD1,500 ⇒換算￥222,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD2,250 ⇒換算￥333,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
MiMedx Group Inc (MiMedx) is a biopharmaceutical company that develops, manufactures and markets regenerative biologics utilizing human placental allografts. The company provides products such as amniotic membrane, umbilical cord, placental ECM and amniotic fluid. It utilizes proprietary purion process that separates placental tissues, cleans and reassembles layers, and dehydrates the tissue to preserve the key elements associated with healing. MiMedx’s product delivers human extracellular matrix components for regeneration of damaged or diseased tissues. Its products modulate inflammation, reduce scar tissue formation, and enhance healing. The company offers services in the areas of wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic and dental sectors of healthcare. MiMedx is headquartered in Marietta, Georgia, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company MiMedx Group Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
MiMedx Group Inc Company Overview 6
MiMedx Group Inc Company Snapshot 6
MiMedx Group Inc Pipeline Products and Ongoing Clinical Trials Overview 6
MiMedx Group Inc – Pipeline Analysis Overview 9
MiMedx Group Inc – Key Facts 9
MiMedx Group Inc – Major Products and Services 10
MiMedx Group Inc Pipeline Products by Development Stage 11
MiMedx Group Inc Ongoing Clinical Trials by Trial Status 13
MiMedx Group Inc Pipeline Products Overview 15
AmnioFix Injectable – Achilles Tendonitis 15
AmnioFix Injectable – Achilles Tendonitis Product Overview 15
AmnioFix Injectable – Achilles Tendonitis Clinical Trial 16
AmnioFix Injectable – Knee OA Pain 17
AmnioFix Injectable – Knee OA Pain Product Overview 17
AmnioFix Injectable – Knee OA Pain Clinical Trial 18
AmnioFix Injectable – Plantar Fasciitis 19
AmnioFix Injectable – Plantar Fasciitis Product Overview 19
AmnioFix Injectable – Plantar Fasciitis Clinical Trial 20
AmnioFix Injectable – Pressure Ulcer 21
AmnioFix Injectable – Pressure Ulcer Product Overview 21
CollaFix – Foot & Ankle 22
CollaFix – Foot & Ankle Product Overview 22
CollaFix – Rotator Cuff Repair 23
CollaFix – Rotator Cuff Repair Product Overview 23
CollaFix BioBraid 24
CollaFix BioBraid Product Overview 24
CollaFix Collagen Fiber Suture 25
CollaFix Collagen Fiber Suture Product Overview 25
CollaFix Tendon Protector 26
CollaFix Tendon Protector Product Overview 26
EpiFix Amniotic Membrane Allograft 27
EpiFix Amniotic Membrane Allograft Product Overview 27
EpiFix Amniotic Membrane Allograft Clinical Trial 28
SaluDisc 30
SaluDisc Product Overview 30
MiMedx Group Inc – Key Competitors 31
MiMedx Group Inc – Key Employees 32
MiMedx Group Inc – Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Recent Developments 35
MiMedx Group Inc, Recent Developments 35
Jul 02, 2018: MiMedx Announces Leadership Changes And Corporate Actions 35
Jun 07, 2018: MiMedx Announces Executive to Lead its International Operations and Provides Update on Company’s International Progress 36
Jun 07, 2018: MiMedx to restate certain historical financial statements 37
Apr 26, 2018: MiMedx Reports Unreviewed First Quarter Revenue Exceeded Upper End Of Its Guidance 38
Mar 28, 2018: MiMedx Enrolls First Patient In Its Phase 2B Clinical Trial Of RMAT Designated AmnioFix Injectable For The Treatment Of Osteoarthritis Of The Knee 39
Mar 15, 2018: MiMedx Announces Expectation to Exceed the $92 Million Top End of First Quarter Revenue Guidance 40
Mar 09, 2018: AmnioFix Injectable Granted Regenerative Medicine Advanced Therapy (RMAT) Designation by the FDA for the Treatment of Osteoarthritis of the Knee 40
Mar 02, 2018: MiMedx Receives Notice of Filing Delinquency from NASDAQ 41
Jan 17, 2018: MiMedx Announces the Enrollment of the First Patients in the Phase 3 Clinical Trial of AmnioFix Injectable for Achilles Tendonitis 41
Jan 16, 2018: MiMedx Announces First Patients Have Been Enrolled In The Phase 3 Clinical Trial Of AmnioFix Injectable In Patients With Recalcitrant Plantar Fasciitis Pain 42
Appendix 43
Methodology 43
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
MiMedx Group Inc Pipeline Products and Ongoing Clinical Trials Overview 6
MiMedx Group Inc Pipeline Products by Equipment Type 7
MiMedx Group Inc Pipeline Products by Indication 8
MiMedx Group Inc Ongoing Clinical Trials by Trial Status 8
MiMedx Group Inc, Key Facts 9
MiMedx Group Inc, Major Products and Services 10
MiMedx Group Inc Number of Pipeline Products by Development Stage 11
MiMedx Group Inc Pipeline Products Summary by Development Stage 12
MiMedx Group Inc Ongoing Clinical Trials by Trial Status 13
MiMedx Group Inc Ongoing Clinical Trials Summary 14
AmnioFix Injectable - Achilles Tendonitis - Product Status 15
AmnioFix Injectable - Achilles Tendonitis - Product Description 15
AmnioFix Injectable - Achilles Tendonitis - A Phase III Achilles Tendonitis Clinical Study of Investigational New Drug (IND) 16
AmnioFix Injectable - Knee OA Pain - Product Status 17
AmnioFix Injectable - Knee OA Pain - Product Description 17
AmnioFix Injectable - Knee OA Pain - A Phase IIb, Prospective, Double-blinded, Randomized Controlled Study of Regenerative Medicine Advanced Therapy (RMAT) Designated AmnioFix Injectable in the Treatment of Knee Osteoarthritis 18
AmnioFix Injectable - Plantar Fasciitis - Product Status 19
AmnioFix Injectable - Plantar Fasciitis - Product Description 19
AmnioFix Injectable - Plantar Fasciitis - A Prospective, Single-blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to the Saline Placebo Injection in the Treatment of Plantar Fasciitis 20
AmnioFix Injectable - Plantar Fasciitis - Prospective, Double-blinded, Randomized Controlled Trial of AmnioFix Injectable as Compared to a Saline Placebo Injection in the Treatment of Plantar Fasciitis 20
AmnioFix Injectable - Pressure Ulcer - Product Status 21
AmnioFix Injectable - Pressure Ulcer - Product Description 21
CollaFix - Foot & Ankle - Product Status 22
CollaFix - Foot & Ankle - Product Description 22
CollaFix - Rotator Cuff Repair - Product Status 23
CollaFix - Rotator Cuff Repair - Product Description 23
CollaFix BioBraid - Product Status 24
CollaFix BioBraid - Product Description 24
CollaFix Collagen Fiber Suture - Product Status 25
CollaFix Collagen Fiber Suture - Product Description 25
CollaFix Tendon Protector - Product Status 26
CollaFix Tendon Protector - Product Description 26
EpiFix Amniotic Membrane Allograft - Product Status 27
EpiFix Amniotic Membrane Allograft - Product Description 27
EpiFix Amniotic Membrane Allograft - Clinical Evaluation of EpiFix in venous leg ulcers ("VLUs") 28
EpiFix Amniotic Membrane Allograft - Dehydrated Human Amnion Chorion Membrane (dHACM) Versus Control in the Treatment of Partial Thickness Burns 28
EpiFix Amniotic Membrane Allograft - Limb Salvage Through Tissue Engineering: A Novel Treatment Modality Using Dehydrated Human Amnion/Chorion Membrane 28
EpiFix Amniotic Membrane Allograft - The Registry of Cellular and Tissue Based Therapies for Chronic Wounds and Ulcers 29
SaluDisc - Product Status 30
SaluDisc - Product Description 30
MiMedx Group Inc, Key Employees 32
MiMedx Group Inc, Subsidiaries 34
Glossary 45

List of Figures
MiMedx Group Inc Pipeline Products by Equipment Type 7
MiMedx Group Inc Pipeline Products by Development Stage 11
MiMedx Group Inc Ongoing Clinical Trials by Trial Status 13

★海外企業調査レポート[MiMedx Group Inc – Product Pipeline Analysis, 2018 Uate]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Lund University：製薬・医療：M&Aディール及び事業提携情報
    Summary Lund University (LNU) is an educational service provider that offers master and bachelor programmes. It offers education and research in the areas of engineering, economics and management, science, law, social sciences, medicine, humanities, theology, fine art, music and others. The universi …
  • HollyFrontier Corp (HFC)：企業の財務・戦略的SWOT分析
    HollyFrontier Corp (HFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Smith Micro Software Inc (SMSI)：企業の財務・戦略的SWOT分析
    Summary Smith Micro Software Inc (Smith Micro) is a software development company that develops productivity and graphic software products for professional artists and general consumers. The company offers products such as NetWise, QuickLink, consumer and CommSuite products. Its NetWise products comp …
  • Verbund AG (VER)：電力：M&Aディール及び事業提携情報
    Summary Verbund AG (Verbund) is an electricity utility that generates, transmits, trades, and distributes electricity. It generates from renewable energy sources such as hydropower, biomass, wind, and solar power. The company constructs, operates and maintains power plants; trades electricity and ga …
  • Clinigen Group Plc (CLIN)：企業の財務・戦略的SWOT分析
    Summary Clinigen Group Plc (Clinigen Group) operates as a pharmaceutical and services company that provides access to clinical trials, medicines, unlicensed and commercial supply. The company acquires and licenses essential commercial medicines such as foscavir, cardioxane, ethyol, savene and vibati …
  • Saigon Thuong Tin Commercial Joint Stock Bank：企業の戦略・SWOT・財務分析
    Saigon Thuong Tin Commercial Joint Stock Bank - Strategy, SWOT and Corporate Finance Report Summary Saigon Thuong Tin Commercial Joint Stock Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • ProvInce of Manitoba：企業の戦略的SWOT分析
    ProvInce of Manitoba - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • TTCL Public Company Limited (TTCL)：電力：M&Aディール及び事業提携情報
    Summary TTCL Public Company Limited (TTCL), a subsidiary of Italian-Thai Development Public Company Limited, is a provider of engineering and construction services. The company offers integrated engineering, procurement and construction (EPC) services, feasibility study and project management servic …
  • Alembic Pharmaceuticals Ltd (APLLTD)：企業の財務・戦略的SWOT分析
    Summary Alembic Pharmaceuticals Ltd (APL) is a pharmaceutical company which manufactures and markets generic pharmaceutical products. The company’s active pharmaceutical ingredients include macrolides, NSAIDs, and other drugs. APL also offers branded formulations in the areas of antibiotics and anti …
  • Emerson Electric Co (EMR)：企業の財務・戦略的SWOT分析
    Emerson Electric Co (EMR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Tolero Pharmaceuticals Inc-製薬・医療分野：企業M&A・提携分析
    Summary Tolero Pharmaceuticals Inc (Tolero), a subsidiary of Dainippon Sumitomo Pharma America Holdings Inc, is a drug company that offers medicines to treat cancer and other serious human diseases. The company’s alvocidib is a cyclin dependent kinase inhibitor with selective activity against CDK9 a …
  • Bioxyne Ltd (BXN)：企業の財務・戦略的SWOT分析
    Bioxyne Ltd (BXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Baltimore Gas and Electric Co：企業の戦略的SWOT分析
    Baltimore Gas and Electric Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Unisem (M) Berhad (UNISEM)：企業の財務・戦略的SWOT分析
    Unisem (M) Berhad (UNISEM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Bakkavor Group Limited：企業の戦略・SWOT・財務情報
    Bakkavor Group Limited - Strategy, SWOT and Corporate Finance Report Summary Bakkavor Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Krystal Biotech Inc (KRYS)：製薬・医療：M&Aディール及び事業提携情報
    Summary Krystal Biotech Inc (Krystal Biotech) is a drug development company that uses gene therapy to develop novel treatments for skin diseases. The company’s pipeline products include KB103, KB105, and KB200. Its products are used for the treatment of dystrophic EB, TGM1-deficient autosomal recess …
  • Lees Foods Ltd.：企業の戦略・SWOT・財務分析
    Lees Foods Ltd. - Strategy, SWOT and Corporate Finance Report Summary Lees Foods Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • IAV GmbH：企業の戦略的SWOT分析
    IAV GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Orpak Systems Limited：企業の戦略的SWOT分析
    Orpak Systems Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Robert Half International Inc.：企業の戦略・SWOT・財務情報
    Robert Half International Inc. - Strategy, SWOT and Corporate Finance Report Summary Robert Half International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆